Drug General Information
Drug ID	D03OGQ
Former ID	DIB013151
Drug Name	AZD-7009
Synonyms	AR-H065522XX; AZD-7009; AZD-7009 (iv formulation, atrial fibrillation conversion)
Drug Type	Small molecular drug
Indication	Atrial fibrillation [ICD9: 272, 427.31; ICD10:E78, I48]		Phase 2	[521760]
Company	AstraZeneca plc
Structure		Download 2D MOL 3D MOL
Formula	C23H34N4O5
Canonical SMILES	N1(CC(=O)C(C)(C)C)CC2OC(C1)CN(C2)CCCNc1ccc(C#N)cc1
CAS Number	CAS 335619-12-0
PubChem Compound ID	9876235
Target and Pathway
Target(s)	Potassium channel	Target Info	Modulator	[532667]
References
Ref 521760	ClinicalTrials.gov (NCT00255281) Efficacy and Safety of AZD7009 in the Treatment of Atrial Fibrillation. U.S. National Institutes of Health.
Ref 532667	Rapid slowing of the atrial fibrillatory rate after administration of AZD7009 predicts conversion of atrial fibrillation. J Electrocardiol. 2014 May-Jun;47(3):316-23.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.